HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

KR33493

an inhibitor of FAS-associated factor 1 (FAF1); structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Acetamides: 21
    - KR33493: 1
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - Acetamides: 21
        KR33493: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - KR33493: 1

Experts

1.	Jeong, Jong-Woo: 1 article (11/2016)
2.	Kim, Eunhee: 1 article (11/2016)
3.	Koo, Tae-Sung: 1 article (11/2016)
4.	Lee, Jong-Hwa: 1 article (11/2016)
5.	Moon, Kyoung-Sik: 1 article (11/2016)
6.	Yoo, Sung-Eun: 1 article (11/2016)
7.	Yu, Changsun: 1 article (11/2016)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 11/01/2016 - "KR33493, a newly developed FAS-associated factor 1 (FAF1) inhibitor for Parkinson's disease, is being evaluated in a Phase I clinical trial. "